BridgeBio Oncology Therapeutics, Inc. (BBOT) › Net IncomeBridgeBio Oncology Therapeutics, Inc. (BBOT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2023: -$41.7K2024: -$74.28M2025: -$134.04M-$134.04M2023Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$134.04M-80.5%2024-$74.28M-178051.7%2023-$41.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share